Upstream authorisation dossiers: difficulties confirmed by ECHA

Published 

Upstream authorisation dossiers: analysis of alternative plans confirm difficulties

ECHA, and more specifically the Socio-Economic Analysis Committee (SEAC), was asked to analyse substitution plans provided by applicants for authorisation, which concern in particular the use of hexavalent chromium in surface treatment, but also the hardener MOCA.

The draft SEAC opinion presented to MOCA's "upstream" applicants at the end of March would cast doubt on the credibility of the substitution plan which covers application sectors as varied as aeronautics, automobiles, ceramics, the paper industry, steel, aluminium, etc.

No information has yet emerged on SEAC's analysis of the substitution plan submitted by CTACSub applicants for the use of decorative chromium, which also covers a wide range of sectors, and which is obviously eagerly awaited by many chromium producers across Europe.

SEAC's final opinion on the substitution plan submitted for the upstream MOCA application, as well as that for the decorative chrome use of CTACSub is expected in June this year. The European Commission's decision on these applications is expected in January 2022.

CTACSub: complicated authorisation dossiers

The CTACSub consortium's application for authorisation was originally submitted in 2015 for six different uses of chromium trioxide. This application is referred to as an upstream authorisation dossier. This means that these dossiers cover all downstream users in the supply chain.

Five of the six applications for chromium VI were validated last December, but application No. 3, functional chromium plating for decorative purposes, is still awaiting a decision. At the request of the European Commission, the consortium has therefore submitted a substitution plan, which confirms the difficulties linked to the upstream dossiers.

Do not hesitate to consult our ongoing webinars regularly to keep up to date with the latest developments of the Commission.

Wish to know more about the REACH Authorisation process?

For more information, do not hesitate to contact Fang Zhou or one of our experts!

Contact us

Encore +

Articles similaires

Tous
REACH Authorization
10
/
8
/
2024

Latest Regulatory News on Chrome VI: Impact for Users

Hexavalent chromium (CrVI), identified as a carcinogenic, mutagenic and reprotoxic substance under the REACH regulation, remains widely used in industry despite its ban in Europe since 2017. The partial annulment of authorizations by the Court of Justice of the European Union has led to stricter requirements to demonstrate the absence of safe alternatives.
Biocides
9
/
30
/
2024

Biocidal Products: Labels and Claims in the EU

Biocidal products are substances designed to control harmful organisms through chemical or biological means. The regulatory framework governing these products in the EU is primarily based on Regulation (EU) No. 528/2012 (BPR), which outlines the requirements for placing these products on the market, including strict rules on labelling and claims. This article summarizes key points from a recent webinar on the subject, covering the regulatory landscape, labelling requirements, and best practices for making compliant claims.
Cosmetics
9
/
11
/
2024

Understanding the Regulation of Cosmetic Ingredients in Europe: 5 Key Facts

The regulation of cosmetic ingredients in the European Union (EU) is stringent and designed to ensure consumer safety. Cosmetic ingredients are regulated under the EU Cosmetic Product Regulation EU 1223/2009, where ingredients of concern are categorized as prohibited, restricted, or authorized substances, primarily outlined in Annexes II to VI.